Details of the Drug Reposition

General Information of This Drug (ID: DMAXBCB)

Drug Name
Axalimogene filolisbac   DMAXBCB
Synonyms AXAL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Cervical cancer DISFSHPF 2C77.0 Phase 3 [1]
------------------------------------------------------------------------------------
2 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Anal cancer DISQUZFO 2C00 Phase 2 [2]
Head and neck cancer DISBPSQZ 2D42 Phase 2 [2]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)